Kelsey Goodwin

Stock Analyst at Guggenheim

(0.29)
# 2564
Out of 5,331 analysts
18
Total ratings
41.67%
Success rate
-7.16%
Average return
Main Sectors:
Top Industries:
9 Stocks
Name Action PT Current % Upside Ratings Updated
URGN UroGen Pharma
Reiterates: Buy
n/a
n/a n/a 2 Apr 29, 2025
IPSC Century Therapeutics
Reiterates: Buy
n/a
n/a n/a 3 Mar 28, 2025
GNLX Genelux
Initiates Coverage On: Buy
8
2.6 207.69% 1 Oct 29, 2024
NUVL Nuvalent
Maintains: Strong Buy
99 105
77.59 35.33% 2 Sep 16, 2024
MGNX Macrogenics
Downgrades: Neutral
n/a
n/a n/a 1 Jul 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 Sep 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
n/a
n/a n/a 3 Jun 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Oct 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Oct 31, 2022